Menu SECTIONS
  • News
  • Features
  • CME
  • Conferences
  • Clinical Tools
  • Special Collections
  • Multimedia
  • Topics
    • Abdominal Infections
    • Bone and Joint Infections
    • Cardiovascular Infections
    • Central Nervous System Infections
    • Covid 19 News & Insights
    • Eye Infections
    • Gastrointestinal Infections
    • General Infectious Disease
    • General Medicine
    • Hepatitis
    • HIV/AIDS
    • Infection Control and Prevention
    • Nosocomial Infections
    • Pleuropulmonary and Bronchial Infections
    • Reproductive Organ Infections and Sexually Transmitted Infections
    • Sepsis
    • Skin and Soft Tissue Infection
    • Upper Respiratory Tract Infections
    • Urinary Tract Infection
    • Vector-Borne Illnesses
  • Haymarket Medical Network
    • Cancer Therapy Advisor
    • Clinical Advisor
    • Clinical Pain Advisor
    • Dermatology Advisor
    • Endocrinology Advisor
    • Gastroenterology Advisor
    • Hematology Advisor
    • Infectious Disease Advisor
    • MPR
    • Medical Bag
    • Neurology Advisor
    • Oncology Nurse Advisor
    • Ophthalmology Advisor
    • Optometry Advisor
    • Psychiatry Advisor
    • Pulmonology Advisor
    • Rare Disease Advisor
    • Renal and Urology News
    • Rheumatology Advisor
    • The Cardiology Advisor
  • COVID-19
  • News
  • CME
  • Drugs
  • Calculators
  • Charts
  • Resources
  • Multimedia
  • Meetings
  • Jobs
Part of the
  • News and Features
  • CME
  • Conferences
  • Clinical Tools
  • Special Collections
  • Multimedia

news
Novel Fluticasone Delivery Reduces Acute Exacerbation Risk in Chronic Rhinosinusitis

Researchers evaluated whether a novel fluticasone exhalation delivery system decreases the risk for acute exacerbations in chronic rhinosinusitis.

Publish Date October 27, 2022
news
Vilobelimab Reduces Mortality Risk in Patients With Severe COVID-19 Pneumonia

Researchers evaluated the effects of vilobelimab among hospitalized patients with severe COVID-19 pneumonia.

Publish Date October 27, 2022
news
An Inhaled IFN-β Treatment May Decrease Risk for Long COVID-19 Symptoms

Researchers evaluated the effects of an inhaled interferon- β-1a nebulizer solution on symptoms of Long COVID-19 infection.

Publish Date October 27, 2022
news
Monkeypox MVA-BN® Vaccine Elicits Durable Immunity for 2 Years With Single Dose

Researchers compared the effects of a 1- vs 2-dose strategy for administration of the MVA-BN® monkeypox vaccine, followed by a booster dose.

Publish Date October 27, 2022
news
Oral Capsule Effective as Fecal Microbiota Transplant Delivery Strategy

Researchers evaluated 4 fecal microbiota transplantation delivery methods for safety and efficacy.

Publish Date October 25, 2022
news
Novel Immunoassay Stratifies Between Bacterial, Viral Infections in Children

Researchers assessed the efficacy of MeMed BV score in differentiating between bacterial and viral infections.

Publish Date October 25, 2022
news
Procalcitonin Predicts Recurrence or Death After Ventilator-Associated Pneumonia

A study was conducted to determine the effect of end-of-treatment procalcitonin levels in patients with VAP on recurrence and death.

Publish Date October 25, 2022
news
Preventive Interventions Are Needed for Invasive Extraintestinal E coli Disease

Researchers evaluated the clinical profile of invasive extraintestinal Escherichia coli disease in older adults.

Publish Date October 25, 2022
news
Antibiotic Overuse Common in Children Hospitalized With COVID-19

Researchers evaluated the rate of antibiotic use among children hospitalized with COVID-19 infection.

Publish Date October 25, 2022
news
Vaccination Status Not Associated With Acute Thromboembolism Risk in COVID-19

Researchers assessed the incidence of acute thromboembolism among vaccinated and unvaccinated adults hospitalized with COVID-19 infection.

Publish Date October 25, 2022
news
Elevated ALT Following Hepatitis C Treatment May Indicate Treatment Failure

Researchers sought to determine if stratifying patients with hepatitis C infection via liver function can decrease cost for determining treatment failure.

Publish Date October 24, 2022
news
Risk Factors for Progression to Hospital-Onset C difficile Infection in Colonized Patients

Researchers assessed patients with C difficile colonization to determine risk factors associated with progression to hospital-onset C difficile infection.

Publish Date October 24, 2022
news
Antiretroviral Therapy Discontinuation Common After Regimen Switch Despite Suppression

Researchers evaluated the rate of virologic failure and treatment discontinuations among antiretroviral therapy-experienced patients with HIV who switched regimens.

Publish Date October 24, 2022
news
Cefepime-Taniborbactam Superior to Meropenem for Complicated UTI

Researchers compared the effects of cefepime-taniborbactam with meropenem in adults with complicated urinary tract infection, including acute pyelonephritis.

Publish Date October 24, 2022
news
Recombinant Zoster Vaccine Confers Long-Term Protection in Older Adults

Researchers evaluated long-term outcomes among older adults to assess the efficacy of an adjuvanted recombinant zoster vaccine against herpes zoster infection.

Publish Date October 24, 2022
news
Subcutaneous Lenacapavir Effective for Patients With Multidrug-Resistant HIV

Researchers evaluated the efficacy of subcutaneous lenacapavir in heavily treatment-experienced patients with multidrug-resistant HIV.

Publish Date October 24, 2022
news
Is Fidaxomicin Superior to Vancomycin for Patients Hospitalized With C difficile Infection?

Researchers evaluated the effects of fidaxomicin compared with vancomycin for the treatment of Clostridioides difficile infection.

Publish Date October 21, 2022
news
High-Dose Superior to Standard-Dose Influenza Vaccination in Older Adults

Researchers compared the relative efficacy and effectiveness of high- vs standard-dose influenza vaccination among older adults.

Publish Date October 21, 2022
news
High-Dose Dexamethasone May Be Harmful for Patients With COVID-19

Researchers evaluated outcomes among patients hospitalized with COVID-19 who received high- vs standard-dose dexamethasone.

Publish Date October 21, 2022
news
Bictegravir/Emtricitabine/Tenofovir Alafenamide Effective for Advanced HIV

Researchers evaluated long-term outcomes among patients with HIV infection who received bictegravir/emtricitabine/tenofovir alafenamide.

Publish Date October 21, 2022
news
Individuals With HIV and Cognitive Impairment at Increased Risk for COVID-19 Mortality

Researchers determined the effect of cognitive impairment on COVID-19 outcomes in people living with HIV.

Publish Date October 21, 2022
news
Ridinilazole Reduces C difficile Infection Recurrence More Effectively Than Vancomycin

Researchers compared the efficacy and safety of ridinilazone with vancomycin for the treatment of Clostridioides difficile infection.

Publish Date October 21, 2022
  • Latest News Your top articles for Monday

    For More Personalized News
  • Haymarket Medical NetworkTop Picks

  • Loading...

    Continuing Medical Education (CME/CE) Courses

    Show More

    • ABOUT
    • ADVERTISE
    • CONNECT
    Remarkable healthcare content
    Cancer Therapy Advisor
    Clinical Advisor
    Clinical Pain Advisor
    Dermatology Advisor
    Endocrinology Advisor
    Gastroenterology Advisor
    Hematology Advisor
    Infectious Disease Advisor
    MPR
    McKnight’s Home Care
    McKnight’s Long-term Care
    McKnight’s Senior Living
    Medical Bag
    Neurology Advisor
    Oncology Nurse Advisor
    Ophthalmology Advisor
    Optometry Advisor
    Psychiatry Advisor
    Pulmonology Advisor
    Rare Disease Advisor
    Renal and Urology News
    Rheumatology Advisor
    The Cardiology Advisor
    myCME

    Copyright © 2023 Haymarket Media, Inc. All Rights Reserved. This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media’s Privacy Policy and Terms & Conditions.

    Loading...
    Loading...